Already a monolith in the clinical testing space, Labcorp is aiming to further swell its testing capabilities with the acquisition of contract research organization Toxikon. The CRO provides ...
“Adding Toxikon underscores our commitment to nonclinical development and advances our capabilities for both drug development and medical device testing,” said Dr. Paul Kirchgraber, CEO of Labcorp ...
The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will enable ...
Nonprofit health system Ascension has inked a strategic relationship with clinical laboratory network Labcorp, in a deal that should expand its testing capabilities. Under the terms of the deal, ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company. The new test ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of the first widely accessible test that provides direct evidence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results